CYTEK BIOSCIENCES, INC. Operating Cash Flow
CYTEK BIOSCIENCES, INC. (CTKB) reported Operating Cash Flow of -$1.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $1.37M, a 1165.74% increase year-over-year.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.74M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$771.00K, a 138.61% decline year-over-year.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.90M, a 129.48% decline year-over-year.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$4.69M, a 118.46% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2024 was $25.38M, a 380.57% increase from fiscal 2023.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2023 was $5.28M.
- CYTEK BIOSCIENCES, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$12.23M, a 364.17% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.37M 10-Q · filed 2026-08-05 | -$2.14M derived: sum of 3 quarters · filed 2026-08-05 | -$6.04M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$2.74M 10-Q · filed 2026-05-07 | -$3.51M derived: sum of 2 quarters · filed 2026-05-07 | -$7.41M derived: sum of 3 quarters · filed 2026-05-07 | -$7.30M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$771.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$4.67M derived: sum of 2 quarters · filed 2026-02-26 | -$4.56M derived: sum of 3 quarters · filed 2026-08-05 | -$4.69M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.79M derived: sum of 2 quarters · filed 2026-08-05 | -$3.92M 10-Q · filed 2025-11-05 | -$1.92M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $108.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$17.00K 10-Q · filed 2026-08-05 | $1.98M derived: sum of 3 quarters · filed 2026-08-05 | $15.20M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$125.00K 10-Q · filed 2026-05-07 | $1.87M derived: sum of 2 quarters · filed 2026-05-07 | $15.09M derived: sum of 3 quarters · filed 2026-05-07 | $21.30M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.22M derived: sum of 2 quarters · filed 2026-02-26 | $21.42M derived: sum of 3 quarters · filed 2026-02-26 | $25.38M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $13.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $19.43M derived: sum of 2 quarters · filed 2025-11-05 | $23.38M 10-Q · filed 2025-11-05 | $32.89M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $10.16M 10-Q · filed 2025-08-06 | $19.67M derived: sum of 3 quarters · filed 2026-02-26 | $15.43M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $3.96M 10-Q · filed 2025-05-08 | $13.47M derived: sum of 2 quarters · filed 2026-02-26 | $9.23M derived: sum of 3 quarters · filed 2026-02-26 | $6.38M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $9.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.27M derived: sum of 2 quarters · filed 2026-02-26 | $2.42M derived: sum of 3 quarters · filed 2026-02-26 | $5.28M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$4.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$7.09M derived: sum of 2 quarters · filed 2024-11-07 | -$4.23M 10-Q · filed 2024-11-07 | $1.96M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $8.00K 10-Q · filed 2024-08-06 | $6.20M derived: sum of 3 quarters · filed 2025-02-28 | -$1.30M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $2.86M 10-Q · filed 2024-05-08 | $9.05M derived: sum of 2 quarters · filed 2025-02-28 | $1.55M derived: sum of 3 quarters · filed 2025-02-28 | -$7.89M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $6.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$1.31M derived: sum of 2 quarters · filed 2025-02-28 | -$10.75M derived: sum of 3 quarters · filed 2025-02-28 | -$12.23M 10-K · filed 2025-02-28 | |
| 2022-09-30 | -$7.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$16.94M derived: sum of 2 quarters · filed 2023-11-14 | -$18.42M 10-Q · filed 2023-11-14 | -$12.98M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-06-30 | -$9.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$10.92M 10-Q · filed 2023-08-08 | -$5.47M derived: sum of 3 quarters · filed 2024-03-13 | -$4.31M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-03-31 | -$1.48M 10-Q · filed 2023-05-09 | $1.48M 10-Q · filed 2022-05-12 | $3.97M derived: sum of 2 quarters · filed 2024-03-13 | $5.13M derived: sum of 3 quarters · filed 2024-03-13 | $1.22M derived: sum of 4 quarters · filed 2024-03-13 |
| 2021-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $6.61M derived: sum of 2 quarters · filed 2024-03-13 | $2.69M derived: sum of 3 quarters · filed 2024-03-13 | $4.63M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$2.75M derived: sum of 2 quarters · filed 2022-11-09 | -$818.00K 10-Q · filed 2022-11-09 | $10.82M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | -$3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$1.98M 10-Q · filed 2022-08-10 | $9.66M derived: sum of 3 quarters · filed 2023-03-01 | $11.85M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-03-31 | $1.94M 10-Q · filed 2022-05-12 | $13.58M derived: sum of 2 quarters · filed 2023-03-01 | $15.77M derived: sum of 3 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $11.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $13.83M derived: sum of 2 quarters · filed 2023-03-01 | $15.16M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $3.52M 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $1.32M 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |